Function
Function , a four-year-old Austin startup that provides consumers with recurring lab testing, optional medical imaging, and personalized health insights to monitor risks before symptoms develop, raise d a $450 million round led by General Catalyst's Customer Value Fund .
Position in SVTR
Snapshot 2026-11-04- Startup SignalsTop 10%↓5
- Life SciencesTop 10%↓1
- Healthcare Services#8of 90↓1
- Medical Diagnosis#2of 23–
About
Function , a four-year-old Austin startup that provides consumers with recurring lab testing, optional medical imaging, and personalized health insights to monitor risks before symptoms develop, raise d a $450 million round led by General Catalyst's Customer Value Fund . More here .
Full tier & rationale — an SVTR Intelligence benefit
Capital graph
Investor· 1
Founders / team· 1
Funding history
- 2026-07-30Strategic$450M
Investors · General Catalyst's Customer Value FundSource · prnewswire.com ↗
Comparable companies· by market
This company
BusinessLatest roundTotal raisedDate- Function
Membership-based personal health testing platform (annual fee starting at about $365)…
Strategic · $450M · 2026-07
$450M
United States
BusinessLatest roundTotal raisedDate- Mira
Connected at-home hormone monitor, disposable test sticks, AI analysis app and online hormone health clinic for women trying to conceive…
$5M
$5M - Cityblock Health
A value-based care platform providing primary care, behavioral health…
Series D+ · $1.0B · 2026-08
$1.0B - ClearNote Health
Develops blood-based early cancer screening tests and epigenomics software, using multi-omics analysis and machine learning to identify cancer earlier
Series D+ · $185M · 2026-05
$185M
China
BusinessLatest roundTotal raisedDateEurope
BusinessLatest roundTotal raisedDate- Neko Health
Provides full-body preventive health scans using sensors and blood analysis
Series C · $1.0B · 2026-07
$1.0B - Tucuvi
Voice AI that automates clinical follow-up and care management workflows
Series A · $184M · 2026-01
$184M - Tandem Health
AI clinical assistant for European healthcare providers: pre-visit summaries, real-time consultation transcription…
Series B · $160M · 2026-09
$160M
Other / unspecified
BusinessLatest roundTotal raisedDate- Even Healthcare
Health subscription membership for individuals and businesses (unlimited consultations, free testing)…
Series B · $120M · 2026-10 · Valuation $300M
$120MValuation $300M - Craif
Urine microRNA plus AI early cancer detection service (miSignal) and software medical device development for pancreatic cancer diagnosis
Series D+ · $88M · 2026-08
$88M - Cent
Annual preventive health check protocol for consumers: whole-body MRI, low-dose CT, DEXA, ECG/ultrasound and 100+ blood and urine biomarkers…
Equity + Debt · $5M · 2026-10
$5M
Confirmed rounds only. Matched on subsector, sector, stage and funding scale — each verifiable on the company profiles.
Related coverage
Investors that may fit
Andreessen Horowitz
22 Life Sciences deals in the last 24 months · 20 in Texas Triangle
Request intro →Ranked by each firm’s deals in this sector over the last 24 months, weighted by nearby stage and shared geography. Indicative only — no rating judgment.